• Publications
  • Influence
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses
Abstract Objectives. Alterations of BDNF signalling in major depression (MD) are supported by studies demonstrating decreased levels of the neurotrophin serum and plasma content in MD patients. WeExpand
  • 302
  • 18
Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia
Dysregulation of the inflammatory response system has been linked to pathophysiology of schizophrenia.1,2 Evidence of immune activation has derived from the detection of abnormal levels ofExpand
  • 170
  • 15
  • PDF
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients
Several findings have suggested that the neurotrophin BDNF could contribute to clinical efficacy of antidepressant treatments. The purpose of this study was to analyse if ECT operates a modulation ofExpand
  • 168
  • 13
  • PDF
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.
BACKGROUND Depression has been associated with low brain-derived neurotrophic factor (BDNF) serum levels, while antidepressant drugs appear to mend this alteration. The purpose of this study was toExpand
  • 121
  • 10
  • PDF
Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: a case-control study.
BACKGROUND There is lack of data regarding BDNF serum levels in patients with obsessive-compulsive disorder (OCD). The aims of the present study were: 1) to assess the serum BDNF content in a sampleExpand
  • 71
  • 9
  • PDF
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases
Consistent evidence indicates the involvement of the brain-derived neurotrophic factor (BDNF) in neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD). In theExpand
  • 105
  • 7
  • PDF
VEGF serum levels in depressed patients during SSRI antidepressant treatment
Recent evidence indicates that the vascular endothelial growth factor (VEGF) may be involved in the neuronal mechanisms underlying both the depression aetiology and the response to pharmacologicalExpand
  • 64
  • 7
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder
The brain-derived neurotrophic factor (BDNF) is involved not only in promoting neuronal outgrowth and differentiation, synaptic connectivity and neuronal repair, but also in modulating eatingExpand
  • 61
  • 6
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients
Vascular endothelial growth factor (VEGF) is an angiogenic cytokine, which induces vasopermeability and facilitates neurogenesis and synaptic plasticity in the adult brain. Expression studies inExpand
  • 66
  • 5
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease
Clinical and immunopathological evidence support a potential role of the pro- and anti-inflammatory cytokine network in neurodegeneration of Alzheimer's disease (AD). Moreover, association studiesExpand
  • 49
  • 5